Please assess the completion status of the following clinical trial:

Trial Title: Dysport® Pediatric Lower Limb Spasticity Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged 2 to 17 years with cerebral palsy~* Equinus foot position~* Ambulatory~* Intensity of muscle tone equal to or greater than 2 in affected lower limb, as measured on the Modified Ashworth Scale~Exclusion Criteria:~* Fixed contracture~* Previous phenol, alcohol injection or surgical intervention~* Other neurological / neuromuscular disorder~* Severe athetoid or dystonic movements

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Dysport 10 U/Kg (Type: EXPERIMENTAL): 10 U/Kg per lower limb. Either one or both lower limbs can be treated. Total volume injected, 2ml per leg.
- Dysport 15 U/Kg (Type: EXPERIMENTAL): 15 U/Kg per lower limb. Either one or both lower limbs can be treated. Total volume injected, 2ml per leg.
- Placebo (Type: PLACEBO_COMPARATOR): Total volume to be injected per lower limb - 2ml. Either one or both lower limbs can be treated.

Based on this trial design, predict the completion outcome and termination type (if applicable).